Further evidence supporting a role for targeting NRF2 in PD is the fact that loss of NRF2 in an aSyn overexpressing mouse was shown to result in increased aSyn accumulation and neuronal death [19,20]. The gene discussed is NFE2L2; the disease is Parkinson disease.